China – It's a Big Deal
Wednesday, October 12, 10:30am - 11:45am
M&A and drug development deals between Western and Chinese companies are on the rise. This session will profile one of the most high-profile China-West collaborations of the past year. The principal dealmakers from both companies will be on hand to discuss the deal’s development and will offer candid advice for companies pursuing China-West collaborations.
Bernard Ng, Managing Director, Transaction Advisory Services (China), Ernst & Young
Frank K. Au, Chief Executive Officer, Cowen and Company Asia
Charles Hsu, PhD, MBA, Venture Partner, Mustang Ventures
Mark Lotter, CEO China Operations, SciClone Pharmaceuticals, Inc. and Former CEO, NovaMed
Gary Titus, Chief Financial Officer, SciClone Pharmaceuticals, Inc
Frank K. Au - Frank K. Au is the CEO of Cowen Latitude Asia, the wholly-owned Asia subsidiary of Cowen Group. Mr. Au is responsible for leading all aspects of Cowen’s businesses in Asia including capital markets, M&A and private placements. Prior to his appointment as CEO of Cowen Latitude Asia, Mr. Au was the President and co-founder of Latitude Capital Group, which was acquired by Cowen Group in 2008. He is based in the Firm's Hong Kong office and currently focuses on covering the alternative energy, consumer, health care, industrial, media and technology sectors in Asia.
Mr. Au is currently a Board Director of CDC Software and CDC Games, which are wholly-owned subsidiaries of CDC Corporation (NASDAQ).
Previously, Mr. Au was the Head of Media investment banking in Greater China for Lehman Brothers Asia. Mr. Au has extensive investment banking experience across all areas of corporate finance including equity and debt capital raising, as well as mergers and acquisition advisory having worked in both Lehman's New York and Hong Kong offices in the Technology, Telecom and Industrial/LBO Groups. He was also the President & Co-Founder of Pacific NetMarkets, an Internet technology incubator for companies in the Asia-Pacific region, which raised over US$25 million in venture capital financing.
Mr. Au holds an MBA from Harvard Business School and a BA in Economics/East Asian Studies from Columbia University.